Media Press Kit

We at hVIVO plc (London and Euronext: HVO) are a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. We provide end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

Our fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via our Venn Life Sciences brand, and a lab offering via our hLAB brand, which includes virology, immunology biomarker and molecular testing. We offer additional clinical field trial services such as patient recruitment and clinical trial site services.

We run challenge studies in London from our Whitechapel quarantine clinic, our state-of-the-art QMB clinic with a highly specialised on-site virology and immunology laboratory, and our clinic in Plumbers Row. To recruit volunteers / patients for our studies, we leverage our unique clinical trial recruitment capacity via our FluCamp volunteer screening facilities in London and Manchester.